CA3221494A1 - Cancer detection method, kit, and system - Google Patents
Cancer detection method, kit, and system Download PDFInfo
- Publication number
- CA3221494A1 CA3221494A1 CA3221494A CA3221494A CA3221494A1 CA 3221494 A1 CA3221494 A1 CA 3221494A1 CA 3221494 A CA3221494 A CA 3221494A CA 3221494 A CA3221494 A CA 3221494A CA 3221494 A1 CA3221494 A1 CA 3221494A1
- Authority
- CA
- Canada
- Prior art keywords
- mir
- hsa
- cancer
- mirna
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 213
- 201000011510 cancer Diseases 0.000 title claims abstract description 184
- 238000001514 detection method Methods 0.000 title claims description 35
- 239000002679 microRNA Substances 0.000 claims abstract description 274
- 108091070501 miRNA Proteins 0.000 claims abstract description 232
- 238000000034 method Methods 0.000 claims abstract description 132
- 239000000090 biomarker Substances 0.000 claims abstract description 94
- 230000014509 gene expression Effects 0.000 claims abstract description 61
- 208000020816 lung neoplasm Diseases 0.000 claims abstract description 55
- 230000035945 sensitivity Effects 0.000 claims abstract description 45
- 208000014018 liver neoplasm Diseases 0.000 claims abstract description 21
- 206010061535 Ovarian neoplasm Diseases 0.000 claims abstract description 19
- 208000005718 Stomach Neoplasms Diseases 0.000 claims abstract description 19
- 208000032612 Glial tumor Diseases 0.000 claims abstract description 16
- 206010018338 Glioma Diseases 0.000 claims abstract description 16
- 206010033128 Ovarian cancer Diseases 0.000 claims abstract description 16
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims abstract description 15
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims abstract description 13
- 238000011528 liquid biopsy Methods 0.000 claims abstract description 7
- 208000011932 ovarian sarcoma Diseases 0.000 claims abstract description 7
- 239000002773 nucleotide Substances 0.000 claims description 106
- 125000003729 nucleotide group Chemical group 0.000 claims description 104
- 239000000523 sample Substances 0.000 claims description 69
- 239000002157 polynucleotide Substances 0.000 claims description 66
- 102000040430 polynucleotide Human genes 0.000 claims description 65
- 108091033319 polynucleotide Proteins 0.000 claims description 65
- 150000007523 nucleic acids Chemical class 0.000 claims description 56
- 102000039446 nucleic acids Human genes 0.000 claims description 54
- 108020004707 nucleic acids Proteins 0.000 claims description 54
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 53
- 201000005202 lung cancer Diseases 0.000 claims description 53
- -1 hsa-miR-45 la Proteins 0.000 claims description 39
- 239000012472 biological sample Substances 0.000 claims description 36
- 239000012634 fragment Substances 0.000 claims description 33
- 230000000295 complement effect Effects 0.000 claims description 32
- 238000003757 reverse transcription PCR Methods 0.000 claims description 25
- 108091090409 Homo sapiens miR-5100 stem-loop Proteins 0.000 claims description 24
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 22
- 108091044796 Homo sapiens miR-1290 stem-loop Proteins 0.000 claims description 22
- 108091093160 Homo sapiens miR-1343 stem-loop Proteins 0.000 claims description 22
- 108091064270 Homo sapiens miR-4787 stem-loop Proteins 0.000 claims description 22
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims description 21
- 206010005003 Bladder cancer Diseases 0.000 claims description 19
- 238000003860 storage Methods 0.000 claims description 19
- 201000005112 urinary bladder cancer Diseases 0.000 claims description 19
- 206010017758 gastric cancer Diseases 0.000 claims description 18
- 210000002966 serum Anatomy 0.000 claims description 18
- 201000011549 stomach cancer Diseases 0.000 claims description 18
- 201000007270 liver cancer Diseases 0.000 claims description 16
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 15
- 238000004458 analytical method Methods 0.000 claims description 15
- 238000011156 evaluation Methods 0.000 claims description 15
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims description 13
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims description 13
- 230000003321 amplification Effects 0.000 claims description 13
- 201000004101 esophageal cancer Diseases 0.000 claims description 13
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 13
- 108091044953 Homo sapiens miR-1228 stem-loop Proteins 0.000 claims description 12
- 108091055552 Homo sapiens miR-1268b stem-loop Proteins 0.000 claims description 12
- 108091067635 Homo sapiens miR-187 stem-loop Proteins 0.000 claims description 12
- 108091068837 Homo sapiens miR-29b-1 stem-loop Proteins 0.000 claims description 12
- 108091035089 Homo sapiens miR-4258 stem-loop Proteins 0.000 claims description 12
- 108091034228 Homo sapiens miR-4286 stem-loop Proteins 0.000 claims description 12
- 108091055444 Homo sapiens miR-4454 stem-loop Proteins 0.000 claims description 12
- 108091063646 Homo sapiens miR-5001 stem-loop Proteins 0.000 claims description 12
- 108091038975 Homo sapiens miR-6075 stem-loop Proteins 0.000 claims description 12
- 108091024622 Homo sapiens miR-6765 stem-loop Proteins 0.000 claims description 12
- 108091024424 Homo sapiens miR-6789 stem-loop Proteins 0.000 claims description 12
- 108091024287 Homo sapiens miR-6877 stem-loop Proteins 0.000 claims description 12
- 108091080212 Homo sapiens miR-8073 stem-loop Proteins 0.000 claims description 12
- 206010060862 Prostate cancer Diseases 0.000 claims description 12
- 238000003745 diagnosis Methods 0.000 claims description 12
- 238000002493 microarray Methods 0.000 claims description 12
- 206010009944 Colon cancer Diseases 0.000 claims description 11
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims description 11
- 108091070489 Homo sapiens miR-17 stem-loop Proteins 0.000 claims description 11
- 108091044906 Homo sapiens miR-663b stem-loop Proteins 0.000 claims description 11
- 108091024552 Homo sapiens miR-6746 stem-loop Proteins 0.000 claims description 11
- 238000003559 RNA-seq method Methods 0.000 claims description 11
- 201000009036 biliary tract cancer Diseases 0.000 claims description 11
- 208000020790 biliary tract neoplasm Diseases 0.000 claims description 11
- 210000004369 blood Anatomy 0.000 claims description 11
- 239000008280 blood Substances 0.000 claims description 11
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 10
- 201000002528 pancreatic cancer Diseases 0.000 claims description 10
- 208000008443 pancreatic carcinoma Diseases 0.000 claims description 10
- 238000007477 logistic regression Methods 0.000 claims description 9
- 238000010208 microarray analysis Methods 0.000 claims description 8
- 210000002700 urine Anatomy 0.000 claims description 8
- 108091072927 Homo sapiens miR-1260b stem-loop Proteins 0.000 claims description 7
- 108091044759 Homo sapiens miR-1268a stem-loop Proteins 0.000 claims description 7
- 108091072863 Homo sapiens miR-3131 stem-loop Proteins 0.000 claims description 7
- 108091072688 Homo sapiens miR-3192 stem-loop Proteins 0.000 claims description 7
- 108091060457 Homo sapiens miR-320b-1 stem-loop Proteins 0.000 claims description 7
- 108091062096 Homo sapiens miR-320b-2 stem-loop Proteins 0.000 claims description 7
- 108091035083 Homo sapiens miR-4257 stem-loop Proteins 0.000 claims description 7
- 108091055184 Homo sapiens miR-4513 stem-loop Proteins 0.000 claims description 7
- 108091055357 Homo sapiens miR-4525 stem-loop Proteins 0.000 claims description 7
- 108091023121 Homo sapiens miR-4706 stem-loop Proteins 0.000 claims description 7
- 108091023094 Homo sapiens miR-4708 stem-loop Proteins 0.000 claims description 7
- 108091093122 Homo sapiens miR-4727 stem-loop Proteins 0.000 claims description 7
- 108091093172 Homo sapiens miR-4736 stem-loop Proteins 0.000 claims description 7
- 108091093165 Homo sapiens miR-4740 stem-loop Proteins 0.000 claims description 7
- 108091061677 Homo sapiens miR-654 stem-loop Proteins 0.000 claims description 7
- 108091061569 Homo sapiens miR-663a stem-loop Proteins 0.000 claims description 7
- 108091060464 Homo sapiens miR-668 stem-loop Proteins 0.000 claims description 7
- 108091024427 Homo sapiens miR-6787 stem-loop Proteins 0.000 claims description 7
- 108091024601 Homo sapiens miR-6802 stem-loop Proteins 0.000 claims description 7
- 108091024415 Homo sapiens miR-6840 stem-loop Proteins 0.000 claims description 7
- 108091083050 Homo sapiens miR-7977 stem-loop Proteins 0.000 claims description 7
- 108091080286 Homo sapiens miR-8060 stem-loop Proteins 0.000 claims description 7
- 108091070380 Homo sapiens miR-92a-1 stem-loop Proteins 0.000 claims description 7
- 108091070381 Homo sapiens miR-92a-2 stem-loop Proteins 0.000 claims description 7
- 108091063740 Homo sapiens miR-92b stem-loop Proteins 0.000 claims description 7
- 108091007702 MIR1260B Proteins 0.000 claims description 7
- 238000000636 Northern blotting Methods 0.000 claims description 7
- 238000007901 in situ hybridization Methods 0.000 claims description 7
- 238000011285 therapeutic regimen Methods 0.000 claims description 7
- 108091069019 Homo sapiens miR-124-1 stem-loop Proteins 0.000 claims description 6
- 108091069008 Homo sapiens miR-124-2 stem-loop Proteins 0.000 claims description 6
- 108091069007 Homo sapiens miR-124-3 stem-loop Proteins 0.000 claims description 6
- 108091068845 Homo sapiens miR-29b-2 stem-loop Proteins 0.000 claims description 6
- 108091023103 Homo sapiens miR-4710 stem-loop Proteins 0.000 claims description 6
- 210000003296 saliva Anatomy 0.000 claims description 6
- 108091024577 Homo sapiens miR-6511b-1 stem-loop Proteins 0.000 claims description 5
- 108091059382 Homo sapiens miR-6511b-2 stem-loop Proteins 0.000 claims description 5
- 108091068928 Homo sapiens miR-107 stem-loop Proteins 0.000 claims description 4
- 108091038941 Homo sapiens miR-1199 stem-loop Proteins 0.000 claims description 4
- 108091044921 Homo sapiens miR-1225 stem-loop Proteins 0.000 claims description 4
- 108091044938 Homo sapiens miR-1238 stem-loop Proteins 0.000 claims description 4
- 108091064840 Homo sapiens miR-1469 stem-loop Proteins 0.000 claims description 4
- 108091068998 Homo sapiens miR-191 stem-loop Proteins 0.000 claims description 4
- 108091067471 Homo sapiens miR-211 stem-loop Proteins 0.000 claims description 4
- 108091070494 Homo sapiens miR-22 stem-loop Proteins 0.000 claims description 4
- 108091069063 Homo sapiens miR-23b stem-loop Proteins 0.000 claims description 4
- 108091072912 Homo sapiens miR-3122 stem-loop Proteins 0.000 claims description 4
- 108091072687 Homo sapiens miR-3191 stem-loop Proteins 0.000 claims description 4
- 108091072679 Homo sapiens miR-3194 stem-loop Proteins 0.000 claims description 4
- 108091060471 Homo sapiens miR-320c-1 stem-loop Proteins 0.000 claims description 4
- 108091078079 Homo sapiens miR-320c-2 stem-loop Proteins 0.000 claims description 4
- 108091072689 Homo sapiens miR-320e stem-loop Proteins 0.000 claims description 4
- 108091067008 Homo sapiens miR-342 stem-loop Proteins 0.000 claims description 4
- 108091056656 Homo sapiens miR-3648-1 stem-loop Proteins 0.000 claims description 4
- 108091045458 Homo sapiens miR-3648-2 stem-loop Proteins 0.000 claims description 4
- 108091056607 Homo sapiens miR-3688-1 stem-loop Proteins 0.000 claims description 4
- 108091064272 Homo sapiens miR-3688-2 stem-loop Proteins 0.000 claims description 4
- 108091055647 Homo sapiens miR-4429 stem-loop Proteins 0.000 claims description 4
- 108091055376 Homo sapiens miR-4448 stem-loop Proteins 0.000 claims description 4
- 108091055440 Homo sapiens miR-4455 stem-loop Proteins 0.000 claims description 4
- 108091055366 Homo sapiens miR-4480 stem-loop Proteins 0.000 claims description 4
- 108091055335 Homo sapiens miR-4515 stem-loop Proteins 0.000 claims description 4
- 108091055348 Homo sapiens miR-4529 stem-loop Proteins 0.000 claims description 4
- 108091054145 Homo sapiens miR-4534 stem-loop Proteins 0.000 claims description 4
- 108091023271 Homo sapiens miR-4635 stem-loop Proteins 0.000 claims description 4
- 108091023054 Homo sapiens miR-4652 stem-loop Proteins 0.000 claims description 4
- 108091023056 Homo sapiens miR-4658 stem-loop Proteins 0.000 claims description 4
- 108091023081 Homo sapiens miR-4687 stem-loop Proteins 0.000 claims description 4
- 108091093209 Homo sapiens miR-4718 stem-loop Proteins 0.000 claims description 4
- 108091093144 Homo sapiens miR-4754 stem-loop Proteins 0.000 claims description 4
- 108091064330 Homo sapiens miR-4771-1 stem-loop Proteins 0.000 claims description 4
- 108091064323 Homo sapiens miR-4771-2 stem-loop Proteins 0.000 claims description 4
- 108091064333 Homo sapiens miR-4776-1 stem-loop Proteins 0.000 claims description 4
- 108091064335 Homo sapiens miR-4776-2 stem-loop Proteins 0.000 claims description 4
- 108091058617 Homo sapiens miR-6131 stem-loop Proteins 0.000 claims description 4
- 108091061646 Homo sapiens miR-619 stem-loop Proteins 0.000 claims description 4
- 108091061609 Homo sapiens miR-648 stem-loop Proteins 0.000 claims description 4
- 108091061608 Homo sapiens miR-650 stem-loop Proteins 0.000 claims description 4
- 108091024578 Homo sapiens miR-6717 stem-loop Proteins 0.000 claims description 4
- 108091024289 Homo sapiens miR-6875 stem-loop Proteins 0.000 claims description 4
- 108091083060 Homo sapiens miR-7975 stem-loop Proteins 0.000 claims description 4
- 238000012706 support-vector machine Methods 0.000 claims description 4
- 108091068855 Homo sapiens miR-103a-1 stem-loop Proteins 0.000 claims description 3
- 108091068838 Homo sapiens miR-103a-2 stem-loop Proteins 0.000 claims description 3
- 108091044881 Homo sapiens miR-1246 stem-loop Proteins 0.000 claims description 3
- 108091070492 Homo sapiens miR-23a stem-loop Proteins 0.000 claims description 3
- 108091065453 Homo sapiens miR-296 stem-loop Proteins 0.000 claims description 3
- 108091035094 Homo sapiens miR-4259 stem-loop Proteins 0.000 claims description 3
- 108091093145 Homo sapiens miR-4755 stem-loop Proteins 0.000 claims description 3
- 108091024386 Homo sapiens miR-6861 stem-loop Proteins 0.000 claims description 3
- 108091087068 Homo sapiens miR-920 stem-loop Proteins 0.000 claims description 3
- 238000007637 random forest analysis Methods 0.000 claims description 3
- 108091061603 Homo sapiens miR-651 stem-loop Proteins 0.000 claims description 2
- 108091067269 Homo sapiens miR-371a stem-loop Proteins 0.000 claims 2
- 239000013615 primer Substances 0.000 claims 2
- 239000002987 primer (paints) Substances 0.000 claims 2
- 241001550352 Mirina Species 0.000 claims 1
- LFVPBERIVUNMGV-UHFFFAOYSA-N fasudil hydrochloride Chemical group Cl.C=1C=CC2=CN=CC=C2C=1S(=O)(=O)N1CCCNCC1 LFVPBERIVUNMGV-UHFFFAOYSA-N 0.000 claims 1
- 210000004072 lung Anatomy 0.000 abstract description 12
- 210000004185 liver Anatomy 0.000 abstract description 11
- 210000003445 biliary tract Anatomy 0.000 abstract description 5
- 238000012360 testing method Methods 0.000 description 25
- 108090000623 proteins and genes Proteins 0.000 description 22
- 238000010200 validation analysis Methods 0.000 description 21
- 108020004414 DNA Proteins 0.000 description 18
- 238000012216 screening Methods 0.000 description 17
- 239000002299 complementary DNA Substances 0.000 description 14
- 238000009396 hybridization Methods 0.000 description 13
- 238000010606 normalization Methods 0.000 description 12
- 238000011161 development Methods 0.000 description 11
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 10
- 206010006187 Breast cancer Diseases 0.000 description 9
- 208000026310 Breast neoplasm Diseases 0.000 description 9
- 238000013459 approach Methods 0.000 description 8
- 230000002611 ovarian Effects 0.000 description 8
- 108700011259 MicroRNAs Proteins 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 206010039491 Sarcoma Diseases 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000002496 gastric effect Effects 0.000 description 6
- 230000036961 partial effect Effects 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 102000053602 DNA Human genes 0.000 description 5
- 108091030146 MiRBase Proteins 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000002591 computed tomography Methods 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000001509 sodium citrate Substances 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 238000009534 blood test Methods 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 239000000039 congener Substances 0.000 description 4
- 238000002790 cross-validation Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 108091027963 non-coding RNA Proteins 0.000 description 4
- 102000042567 non-coding RNA Human genes 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 108020004682 Single-Stranded DNA Proteins 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000002512 chemotherapy Methods 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 238000013211 curve analysis Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000002853 nucleic acid probe Substances 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 238000001959 radiotherapy Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- IVDRCZNHVGQBHZ-UHFFFAOYSA-N 2-butoxyethyl 2-(3,5,6-trichloropyridin-2-yl)oxyacetate Chemical compound CCCCOCCOC(=O)COC1=NC(Cl)=C(Cl)C=C1Cl IVDRCZNHVGQBHZ-UHFFFAOYSA-N 0.000 description 2
- 241001463143 Auca Species 0.000 description 2
- 241000972773 Aulopiformes Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 238000001347 McNemar's test Methods 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108091006629 SLC13A2 Proteins 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 208000009956 adenocarcinoma Diseases 0.000 description 2
- 238000013103 analytical ultracentrifugation Methods 0.000 description 2
- 238000002869 basic local alignment search tool Methods 0.000 description 2
- 210000000013 bile duct Anatomy 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 238000004422 calculation algorithm Methods 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 229960000633 dextran sulfate Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- 210000001808 exosome Anatomy 0.000 description 2
- 238000010195 expression analysis Methods 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000012165 high-throughput sequencing Methods 0.000 description 2
- 238000001794 hormone therapy Methods 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000003364 immunohistochemistry Methods 0.000 description 2
- 238000009169 immunotherapy Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 238000009607 mammography Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 238000007481 next generation sequencing Methods 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 108091007428 primary miRNA Proteins 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 206010041823 squamous cell carcinoma Diseases 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000013179 statistical model Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000002626 targeted therapy Methods 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 108010052418 (N-(2-((4-((2-((4-(9-acridinylamino)phenyl)amino)-2-oxoethyl)amino)-4-oxobutyl)amino)-1-(1H-imidazol-4-ylmethyl)-1-oxoethyl)-6-(((-2-aminoethyl)amino)methyl)-2-pyridinecarboxamidato) iron(1+) Proteins 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 108020005345 3' Untranslated Regions Proteins 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 101100421200 Caenorhabditis elegans sep-1 gene Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241001123946 Gaga Species 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 208000003445 Mouth Neoplasms Diseases 0.000 description 1
- 102000048850 Neoplasm Genes Human genes 0.000 description 1
- 108700019961 Neoplasm Genes Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 241000282577 Pan troglodytes Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108091093037 Peptide nucleic acid Proteins 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 241000702619 Porcine parvovirus Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 108020005093 RNA Precursors Proteins 0.000 description 1
- 102000003661 Ribonuclease III Human genes 0.000 description 1
- 108010057163 Ribonuclease III Proteins 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 108091081021 Sense strand Proteins 0.000 description 1
- 108020004688 Small Nuclear RNA Proteins 0.000 description 1
- 102000039471 Small Nuclear RNA Human genes 0.000 description 1
- 108020003224 Small Nucleolar RNA Proteins 0.000 description 1
- 102000042773 Small Nucleolar RNA Human genes 0.000 description 1
- 206010041067 Small cell lung cancer Diseases 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000001369 bisulfite sequencing Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 230000005773 cancer-related death Effects 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 108091092240 circulating cell-free DNA Proteins 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000009615 deamination Effects 0.000 description 1
- 238000006481 deamination reaction Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 238000012350 deep sequencing Methods 0.000 description 1
- 239000000104 diagnostic biomarker Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000001973 epigenetic effect Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000003633 gene expression assay Methods 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000005055 memory storage Effects 0.000 description 1
- 238000010197 meta-analysis Methods 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 108091047577 miR-149 stem-loop Proteins 0.000 description 1
- 108091087639 miR-2861 stem-loop Proteins 0.000 description 1
- 108091069243 miR-4463 stem-loop Proteins 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 238000011330 nucleic acid test Methods 0.000 description 1
- 229940127073 nucleoside analogue Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 238000004803 parallel plate viscometry Methods 0.000 description 1
- 238000003909 pattern recognition Methods 0.000 description 1
- 208000010626 plasma cell neoplasm Diseases 0.000 description 1
- 229920000553 poly(phenylenevinylene) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 230000007859 posttranscriptional regulation of gene expression Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000092 prognostic biomarker Substances 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000010206 sensitivity analysis Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000528 statistical test Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000009452 underexpressoin Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163208506P | 2021-06-09 | 2021-06-09 | |
| US63/208,506 | 2021-06-09 | ||
| PCT/US2022/032423 WO2022261039A2 (en) | 2021-06-09 | 2022-06-07 | Cancer detection method, kit, and system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3221494A1 true CA3221494A1 (en) | 2022-12-15 |
Family
ID=84426392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3221494A Pending CA3221494A1 (en) | 2021-06-09 | 2022-06-07 | Cancer detection method, kit, and system |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP4352266A2 (zh) |
| CN (1) | CN117500941A (zh) |
| AU (1) | AU2022289858A1 (zh) |
| CA (1) | CA3221494A1 (zh) |
| WO (1) | WO2022261039A2 (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019004436A1 (ja) * | 2017-06-29 | 2019-01-03 | 東レ株式会社 | 肺がんの検出のためのキット、デバイス及び方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9495515B1 (en) * | 2009-12-09 | 2016-11-15 | Veracyte, Inc. | Algorithms for disease diagnostics |
| US20120041274A1 (en) * | 2010-01-07 | 2012-02-16 | Myriad Genetics, Incorporated | Cancer biomarkers |
| WO2013107459A2 (en) * | 2012-01-16 | 2013-07-25 | Herlev Hospital | Microrna for diagnosis of pancreatic cancer and/or prognosis of patients with pancreatic cancer by blood samples |
| US9708667B2 (en) * | 2014-05-13 | 2017-07-18 | Rosetta Genomics, Ltd. | MiRNA expression signature in the classification of thyroid tumors |
| WO2016038119A1 (en) * | 2014-09-09 | 2016-03-17 | Istituto Europeo Di Oncologia S.R.L. | Methods for lung cancer detection |
| CA3059480A1 (en) * | 2017-04-28 | 2018-11-01 | Toray Industries, Inc. | Kit, device, and method for detecting ovarian tumor |
-
2022
- 2022-06-07 EP EP22820856.7A patent/EP4352266A2/en active Pending
- 2022-06-07 CN CN202280041034.8A patent/CN117500941A/zh active Pending
- 2022-06-07 AU AU2022289858A patent/AU2022289858A1/en active Pending
- 2022-06-07 CA CA3221494A patent/CA3221494A1/en active Pending
- 2022-06-07 WO PCT/US2022/032423 patent/WO2022261039A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| EP4352266A2 (en) | 2024-04-17 |
| AU2022289858A1 (en) | 2024-01-04 |
| WO2022261039A3 (en) | 2023-01-19 |
| WO2022261039A2 (en) | 2022-12-15 |
| CN117500941A (zh) | 2024-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5843840B2 (ja) | 新しい癌マーカー | |
| ES2656487T3 (es) | Evaluación de la respuesta a la terapia de neoplasmas neuroendocrinos gastroenteropancreáticas (GEP-NEN) | |
| US11198909B2 (en) | Risk scores based on human phosphodiesterase 4D variant 7 expression | |
| JP2014509189A (ja) | 結腸ガン遺伝子発現シグネチャーおよび使用方法 | |
| KR20180009762A (ko) | 폐암을 진단하거나 검출하기 위한 방법 및 조성물 | |
| US10287634B2 (en) | RNA-biomarkers for diagnosing prostate cancer | |
| US10087489B2 (en) | Biomarkers and uses thereof in prognosis and treatment strategies for right-side colon cancer disease and left-side colon cancer disease | |
| EP3548631B1 (en) | Risk scores based on human phosphodiesterase 4d variant 7 expression | |
| CA3221494A1 (en) | Cancer detection method, kit, and system | |
| JP6611411B2 (ja) | 膵臓がんの検出キット及び検出方法 | |
| US20210079479A1 (en) | Compostions and methods for diagnosing lung cancers using gene expression profiles | |
| JP6383541B2 (ja) | 胆管がんの検出キット及び検出方法 | |
| CN112567050A (zh) | 检测方法 | |
| AU2018428853A1 (en) | Methods and compositions for the analysis of cancer biomarkers | |
| US10407737B2 (en) | Methods and kits for identifying pre-cancerous colorectal polyps and colorectal cancer | |
| JP7471601B2 (ja) | 分子シグネチャー及び低悪性度前立腺癌の同定のためのその使用 | |
| US20210025001A1 (en) | Methods for Detecting and Treating Idiopathic Pulmonary Fibrosis | |
| EP2655663A2 (en) | Biomarkers and uses thereof in prognosis and treatment strategies for right-side colon cancer disease and left-side colon cancer disease | |
| JP2024519082A (ja) | 肝細胞がんのｄｎａメチル化バイオマーカー | |
| Lin et al. | POD-02.08: The Positive Expression of ADAM9 Protein was Relative with Disease Progression to Hormonal Refractory and Poor Prognosis for Advanced Prostate Cancer |